PFSRSONJ
Police & Firemen's Retirement System of New Jersey Portfolio holdings
AUM
$10.8B
This Quarter Return
+3.92%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$10.3B
AUM Growth
–
Cap. Flow
+$10.3B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
29.46%
Holding
3,011
New
3,011
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Apple
AAPL
|
$521M |
| 2 |
iShares MSCI India ETF
INDA
|
$494M |
| 3 |
NVIDIA
NVDA
|
$457M |
| 4 |
Microsoft
MSFT
|
$456M |
| 5 |
Amazon
AMZN
|
$300M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 26.94% |
| 2 | Financials | 13.56% |
| 3 | Consumer Discretionary | 11.06% |
| 4 | Healthcare | 9.35% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Nkarta
NKTX
$151M
| $26.5K | ﹤0.01% |
+10,638
| New | +$26.5K |
|
2902
Twin Disc
TWIN
$179M
| $26.4K | ﹤0.01% |
+2,244
| New | +$26.4K |
|
|
SUNS
2903
Sunrise Realty Trust, Inc. Common Stock
SUNS
$148M
| $26.4K | ﹤0.01% |
+1,872
| New | +$26.4K |
|
2904
American Vanguard Corp
AVD
$154M
| $26.3K | ﹤0.01% |
+5,674
| New | +$26.3K |
|
2905
Cartesian Therapeutics
RNAC
$261M
| $26K | ﹤0.01% |
+1,453
| New | +$26K |
|
2906
Commercial Vehicle Group
CVGI
$65.1M
| $25.8K | ﹤0.01% |
+10,407
| New | +$25.8K |
|
2907
Sight Sciences
SGHT
$213M
| $25.7K | ﹤0.01% |
+7,063
| New | +$25.7K |
|
2908
Paysign
PAYS
$282M
| $25.7K | ﹤0.01% |
+8,498
| New | +$25.7K |
|
2909
Ispire Technology
ISPR
$182M
| $25.4K | ﹤0.01% |
+5,049
| New | +$25.4K |
|
2910
Puma Biotechnology
PBYI
$254M
| $25.4K | ﹤0.01% |
+8,322
| New | +$25.4K |
|
|
QIPT
2911
Quipt Home Medical
QIPT
$114M
| $25.1K | ﹤0.01% |
+8,217
| New | +$25.1K |
|
2912
XBiotech
XBIT
$96.3M
| $25K | ﹤0.01% |
+6,328
| New | +$25K |
|
2913
X4 Pharmaceuticals
XFOR
$84.2M
| $24.8K | ﹤0.01% |
+33,784
| New | +$24.8K |
|
2914
Zura Bio
ZURA
$133M
| $24.5K | ﹤0.01% |
+9,812
| New | +$24.5K |
|
2915
Achieve Life Sciences
ACHV
$152M
| $24.4K | ﹤0.01% |
+6,924
| New | +$24.4K |
|
2916
Corbus Pharmaceuticals
CRBP
$115M
| $24.1K | ﹤0.01% |
+2,043
| New | +$24.1K |
|
2917
Biomea Fusion
BMEA
$116M
| $24K | ﹤0.01% |
+6,195
| New | +$24K |
|
2918
Atossa Therapeutics
ATOS
$98.5M
| $24K | ﹤0.01% |
+25,430
| New | +$24K |
|
2919
Foghorn Therapeutics
FHTX
$286M
| $24K | ﹤0.01% |
+5,078
| New | +$24K |
|
2920
Enanta Pharmaceuticals
ENTA
$180M
| $23.9K | ﹤0.01% |
+4,163
| New | +$23.9K |
|
2921
TScan Therapeutics
TCRX
$102M
| $23.5K | ﹤0.01% |
+7,720
| New | +$23.5K |
|
2922
Lineage Cell Therapeutics
LCTX
$267M
| $23.3K | ﹤0.01% |
+46,405
| New | +$23.3K |
|
2923
The Joint Corp
JYNT
$165M
| $23.3K | ﹤0.01% |
+2,189
| New | +$23.3K |
|
|
BLUE
2924
DELISTED
bluebird bio
BLUE
| $22.8K | ﹤0.01% |
+2,731
| New | +$22.8K |
|
2925
Quest Resource Holding
QRHC
$38.6M
| $22.5K | ﹤0.01% |
+3,468
| New | +$22.5K |
|